Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$2.77 USD
+0.11 (4.14%)
Updated May 31, 2024 04:00 PM ET
After-Market: $2.76 -0.01 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.19 | -5.26% |
Earnings Summary
For their last quarter, Lyell Immunopharma (LYEL) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 20.00%. Look out for LYEL's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 26.92%.
Earnings History
Price & Consensus
Zacks News for LYEL
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services